Clinical efficacy of Xiaju Huayu Capsules in treating recurrent angina pec-toris after coronary artery bypass grafting with qi deficiency and blood stasis type
Objective To explore the clinical effect of Xiaju Huayu Capsules in treating recurrent angina pectoris after coronary artery bypass grafting with qi deficiency and blood stasis type.Methods Seventy patients with recurrent angina pectoris after coronary artery bypass grafting ad-mitted to Weifang Traditional Chinese Medicine Hospital in Shandong Province from January to December 2021 were selected as the study subjects.They were divided into the control group and the observation group by random number table method,with 35 cases in each group.The control group received conventional western medicine treatment,while the observation group received conventional western medicine treatment+Xiaju Huayu Capsules.Both groups were treated continuously for three months.The therapeutic effect of traditional Chinese medicine syndromes was compared between two groups.The frequency and duration of angina pectoris,Seattle angina pectoris pectoris scale,N-terminal pro-B-type natriuretic pep-tide(NT-proBNP),and high-sensitivity C-reactive protein(hs-CRP)levels before and after treatment were compared between the two groups.Rel-evant safety indicators of the patients were also recorded.Results The therapeutic effect of traditional Chinese medicine syndrome in the observation group was better than that in the control group(P<0.05).After treatment,the angina frequency in both groups were less than before treatment,the duration in both groups were shorter than before treatment,the angina frequency pectoris in observation group was lower than that in the control group,the duration of observation group was shorter than that in the control group(P<0.05).After treatment,all scores on the Seattle angina pec-toris scale in both groups were higher than those before treatment,and the observation group was higher than the control group(P<0.05).After treatment,the serum NT-proBNP and hs-CRP levels in both groups were lower than those before treatment,and the observation group was low-er than the control group(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Xiaju Huayu Capsules has significant improvement effect on recurrent angina pectoris after coronary artery bypass grafting,and has high safety,which has important clinical application value.